6505--Diltiazem SA Capsules (AB3)

Solicitation / RFP / RFQ

This solicitation seeks proposals for the supply of Diltiazem capsules (various strengths: 120mg, 180mg, 240mg, 300mg, 360mg) in 90-count bottles (Unit of Use). The contract will be a Firm Fixed Price, Indefinite-Delivery Requirements contract. The products will be distributed through the Department of Veterans Affairs (VA) and Department of Defense (DoD) Pharmaceutical Prime Vendor (PPV) Programs.

• Product: Diltiazem capsules in specified strengths and 90-count bottles.

• Packaging: Unit of use bottles with specific safety cap and volume requirements (minimum 120cc volume, cylindrical body, minimum 5.75" circumference, label size 5.25" x 2").

• Identification: Each offered drug must have a unique 11-digit National Drug Code (NDC) number specific to the offeror.

• Quality: All offered pharmaceuticals must be FDA-approved and manufactured in FDA cGMP acceptable facilities. Manufacturing facilities must have FDA clearance for the specific NDA/ANDA/BLA cited.

• Bar Coding: Products must include GS1-128 or HIBCC compliant bar code labeling at the unit-of-use package level.

• DSCSA Compliance: Adherence to Drug Supply Chain Security Act (DSCSA) requirements, including serialized transaction information and statements.

• Cost Recovery Fee: A 0.5% Cost Recovery Fee must be included in all offered prices.

• Letter of Commitment: If the offeror is not the manufacturer, a Letter of Commitment from the manufacturer is required.

• Contract Type: Firm Fixed Price, Indefinite-Delivery Requirements.

• Period of Performance: Base year plus four one-year option periods.

• Award: One award will be made in the aggregate for all line items.

• Submission Method: Proposals must be submitted via email to Christopher.Carthron@va.gov and Diana.Martinez1@va.gov as a PDF copy of the signed SF-1449, along with Word or PDF attachments. Faxed proposals are not acceptable.

• Pricing: Offerors must submit a price for the base year and all four option years for all five line items. Prices should not exceed two decimal places.

• Evaluation: Award will be made to the responsible offeror with the lowest price technically acceptable offer. Technical acceptability includes meeting product descriptions, NDC requirements, FDA approval, cGMP compliance, and manufacturing facility clearance. Past performance will also be evaluated.

• Deadline: Offerors must submit proposals by the exact time specified in the solicitation. Offerors are advised to submit well before the deadline and confirm receipt.

• This acquisition is unrestricted.

• Offerors must maintain a current and accurate record in the System for Award Management (SAM).

• Non-small business concerns may be required to submit a subcontracting plan.

• Attachments A and B list the VA and DoD Pharmaceutical Prime Vendor Contractors.

• Attachment C provides estimated annual requirements by agency for each Diltiazem item.

• Attachment D provides a model outline for a Small Business Subcontracting Plan.

Solicitation / RFP / RFQ

This is a pre-solicitation notice for Request for Proposal (RFP) 36E79726R0022. The Department of Veterans Affairs (VA) National Acquisition Center intends to procure Diltiazem 24Hr Capsules for various federal agencies including VA (CMOPs and SVH), Department of Defense (DoD), Bureau of Prisons (BOP), Indian Health Service (IHS), and Federal Health Care Center (FHCC). The VA will award one contract to a responsible offeror capable of providing an uninterrupted supply.

• The contract will cover Diltiazem (equivalent to Cardizem AB3) in 120mg, 180mg, 240mg, 300mg, and 360mg strengths, supplied in 90-count bottles.

• Estimated annual usage for these items totals over 160,000 bottles across all strengths.

• Offerors must state the exact drug name as it appears on the label and possess a unique NDC number for the product they supply.

• The successful offeror's label with its unique NDC will be the only label permitted on the product; labels cannot be affixed over existing ones.

• Distribution will be managed through the VA’s and DoD’s respective Pharmaceutical Prime Vendor Programs.

• The contract period will be for one year with four pre-priced one-year option periods.

• The solicitation will be issued electronically in accordance with FAR Part 12.

• The anticipated issue date is on or about May 15, 2026.

• The tentative closing date is June 1, 2026.

• Interested offerors should continuously monitor SAM.gov for updates, amendments, and other documents.

• All responsible sources are encouraged to submit timely offers.

• This is an unrestricted procurement.

• The NAICS code for this procurement is 325412.

• No paper copies of the solicitation will be available.

• The point of contact for this procurement is Chris Carthron, Contract Specialist, at Christopher.Carthron@va.gov or (708) 786-4980.